Target Information
General Information of This Target (ID: PATR0YTGZR)
| Target Name | Nicotinamide phosphoribosyltransferase (NAMPT) |
|||||
|---|---|---|---|---|---|---|
| Gene Name | NAMPT |
|||||
| Gene ID | ||||||
| Synonym | PBEF, PBEF1; Pre-B-cell colony-enhancing factor 1; Visfatin |
|||||
| Sequence |
MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFY
GLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVP EGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETS GNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGY SVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIV SRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINT LQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVAD PNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNA QLNIELEAAHH Click to Show/Hide
|
|||||
| Family | the NAPRTase family |
|||||
| Function |
Catalyzes the condensation of nicotinamide with 5- phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway. The secreted form behaves both as a cytokine with immunomodulating properties and an adipokine with anti-diabetic properties, it has no enzymatic activity, partly because of lack of activation by ATP, which has a low level in extracellular space and plasma. Plays a role in the modulation of circadian clock function. NAMPT-dependent oscillatory production of NAD regulates oscillation of clock target gene expression by releasing the core clock component: CLOCK-BMAL1 heterodimer from NAD-dependent SIRT1- mediated suppression.
Click to Show/Hide
|
|||||
| Uniprot Entry | ||||||
| HGNC ID | ||||||
| KEGG ID | ||||||
Full List of The ADC Related to This Target
Investigative
| ADC Name | Antibody | Antigen | Payload | Linker | ADC Info |
|---|---|---|---|---|---|
|
HER2-EC4 DAR7.8
[1]
|
Anti-human HER2 mAb |
Receptor tyrosine-protein kinase erbB-2 (HER2) |
NAMPT inhibitor 5 |
Open-chain glycine maleimide |
|
|
B7H3-EC3 DAR4.1
[1]
|
Anti-human CD276 mAb |
CD276 antigen (CD276) |
NAMPT inhibitor 4 |
Mc-Val-Ala |
|
|
B7H3-EC3 DAR7.8
[1]
|
Anti-human CD276 mAb |
CD276 antigen (CD276) |
NAMPT inhibitor 4 |
Mc-Val-Ala |
|
|
C4.4A-EC4
[1]
|
Anti-human LYPD3 mAb |
Ly6/PLAUR domain-containing protein 3 (LYPD3) |
NAMPT inhibitor 5 |
Open-chain glycine maleimide |
|
|
HER2-EC5
[1]
|
Anti-human HER2 mAb |
Receptor tyrosine-protein kinase erbB-2 (HER2) |
NAMPT inhibitor 6 |
Open-chain glycine maleimide-PEG |
|
|
HER2-EC4 DAR2.7
[1]
|
Anti-human HER2 mAb |
Receptor tyrosine-protein kinase erbB-2 (HER2) |
NAMPT inhibitor 5 |
Open-chain glycine maleimide |
|
|
HER2-EC3
[1]
|
Anti-human HER2 mAb |
Receptor tyrosine-protein kinase erbB-2 (HER2) |
NAMPT inhibitor 4 |
Mc-Val-Ala |
|
|
HER2-EC1
[1]
|
Anti-human HER2 mAb |
Receptor tyrosine-protein kinase erbB-2 (HER2) |
NAMPT inhibitor 4 |
Maleimido-caproyl |
|
|
C4.4A-EC5
[2]
|
Anti-human LYPD3 mAb |
Ly6/PLAUR domain-containing protein 3 (LYPD3) |
NAMPT inhibitor 6 |
Open-chain glycine maleimide-PEG |
|
|
C4.4A-EC3
[1]
|
Anti-human CD276 mAb |
Ly6/PLAUR domain-containing protein 3 (LYPD3) |
NAMPT inhibitor 4 |
Mc-Val-Ala |
|
|
C4.4A-EC2
[1]
|
Anti-human LYPD3 mAb |
Ly6/PLAUR domain-containing protein 3 (LYPD3) |
NAMPT inhibitor 6 |
Maleimido-caproyl |
|
|
C4.4A-EC1
[1]
|
Anti-human LYPD3 mAb |
Ly6/PLAUR domain-containing protein 3 (LYPD3) |
NAMPT inhibitor 4 |
Maleimido-caproyl |
|
|
B7H3-EC5
[1]
|
Anti-human CD276 mAb |
CD276 antigen (CD276) |
NAMPT inhibitor 6 |
Open-chain glycine maleimide-PEG |
|
|
B7H3-EC4
[1]
|
Anti-human CD276 mAb |
CD276 antigen (CD276) |
NAMPT inhibitor 5 |
Open-chain glycine maleimide |
|
|
B7H3-EC2
[1]
|
Anti-human CD276 mAb |
CD276 antigen (CD276) |
NAMPT inhibitor 6 |
Maleimido-caproyl |
|
|
B7H3-EC1
[1]
|
Anti-human CD276 mAb |
CD276 antigen (CD276) |
NAMPT inhibitor 4 |
Maleimido-caproyl |
|
|
CD206-NAMPT inhibitor-based antibody drug conjugate
[3]
|
Undisclosed |
Macrophage mannose receptor 1 (MRC1) |
NAMPT toxophore |
Undisclosed |
|
|
Alpha-human dectin-1-pam3 conjugate
[4]
|
Undisclosed |
C-type lectin domain family 7 member A (CLEC7A) |
NAMPT toxophore |
Undisclosed |
References
